Sumayang, Nolasco L.
HRN: 24-37-97 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/19/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/19/2024
01/25/2024
IV
4.5g
Q8
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes